WHO ICTRP trial
A randomized phase III trial comparing two schedules of rituximab maintenance in…
EUCTR2004-002859-13-SK · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2004-002859-13-SK |
|---|---|
| Public title | A randomized phase III trial comparing two schedules of rituximab maintenance in rituximab-responding patients with untreated, chemotherapy resistant or relapsed follicular lymphoma. |
| Scientific title | A randomized phase III trial comparing two schedules of rituximab maintenance in rituximab-responding patients with untreated, chemotherapy resistant or relapsed follicular lymphoma. |
| Primary sponsor | SIAK |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): Therapeutic exploratory (Phase II): Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): |
| Countries | Slovakia;Italy |
| Conditions | Rituximab maintenance in rituximab-responding patients with untreated, chemotherapy resistant or relapsed follicular lymphoma MedDRA version: 9.1 Level: HLT Classification code 10025634 Term: Lymphomas unclassifiable malignant |
| Interventions | Trade Name: MabThera 100mg Product Name: Mabthera 100 mg Product Code: 59839 Pharmaceutical Form: Concentrate for solution for infusion INN or Proposed INN: Rituximab Concentration unit: mg milligram(s) Concentration type: equal… |
| Registration date | Jan 23, 2007 |
| Target size | 270 |
| Secondary IDs | SAKK 3503;2004-002859-13-IT |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: